The opioid crisis in 2023, amid the Biden administration, cost the U.S. $2.7 trillion, according to a Council of Economic ...
The fentanyl crisis represents a clear and present danger to US national security, requiring a coordinated, sustained, and ...
The White House says fentanyl smuggled to the U.S. justifies tariffs against Canada, China and Mexico. But fentanyl deaths ...
Historic national lawsuit settlements with pharmaceutical companies accused of fueling the opioid crisis will bring millions ...
They acknowledged the need for opioids for managing chronic pain for some but pointed to overprescriptions in the 1990s and 2000s as a major driver of the opioid crisis. They discussed naloxone ...
New synthetic opioids (NSOs) are one of the fastest-growing groups of new psychoactive substances around the world ...
President Trump has threatened to impose tariffs on Canada over drug trafficking, equating it with Mexico. U.S. government ...
A bipartisan coalition of states, including Tennessee, will receive $7.4 billion from Purdue Pharma, Inc. and members of the ...
The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side effects.
Now a third option is available after the U.S. Food and Drug Administration last week approved Vertex Pharmaceuticals’ Suzetrigine, sold as twice-daily Journavx, a non-addictive prescription drug for ...
They acknowledged the need for opioids for managing chronic pain for some but pointed to overprescriptions in the 1990s and 2000s as a major driver of the opioid crisis. They discussed naloxone ...